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Evidence that two phenotypically distinct mouse PKD mutations, bpk
and jcpk, are allelic. Numerous mouse models of polycystic kidney disease
(PKD) have been described. All of these diseases are transmitted as single
recessive traits and in most, the phenotypic severity is influenced by the
genetic background. However, based on their genetic map positions, none
of these loci appears to he allelic and none are candidate modifier loci for
any other mouse PKD mutation. Previously, we have described the mouse
hpk mutation, a model that closely resembles human autosomal recessive
polycystic kidney disease. We now report that the bpk mutation maps to a
1.6cM interval on mouse Chromosome 10, and that the renal cystic disease
severity in our intersubspecific intereross progeny is influenced by the
genetic background. Interestingly, bpk co-localizes with jcpk, a phenotyp-
ically-distinet PKD mutation, and complementation testing indicates that
the bpk and jcpk mutations are allelic. These data imply that distinct PKD
phenotypes can result from different mutations within a single gene. In
addition, based on its map position, the hpk locus is a candidate genetic
modifier for jck, a third phenotypically-distinct PKD mutation.
The formation of renal cysts characterizes several inherited
human disorders. These diseases, which are transmitted as single
Mendelian traits, include: (1) autosomal dominant polycystic
kidney disease (ADPKD), (2) autosomal recessive polycystic
kidney disease (ARPKD), (3) juvenile nephronophthisis-medul-
lary cystic disease complex (JN-MCD), and (4) several multiple
malformation syndromes [ 11. Taken together, these disorders
cause significant morbidity and mortality in both adults and
children. For example, ADPKD causes 10 to 12% of adult
end-stage renal disease (ESRD) [2], while in ARPKD, the
majority of affected children die in the perinatal period [3].
Surviving ARPKD patients, combined with children who have JN,
comprise 6% of all pediatric ESRD patients [I.
Among these inherited disorders, the phenotypic features and
temporal onset of renal cyst formation vary widely. This pheno-
typic variability appears to be the result of several factors,
including: different mutant genes; different mutations within the
same gene; and different genetic backgrounds in which the mutant
gene is expressed. Linkage analyses have identified at least three
distinct loei for ADPKD [5-81: a single locus for ARPKD on
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chromosome 6p [9, 101; at least two separate loci for JN [11, 121;
and single discrete loci for several of the malformation syndromes
[13-15]. Given the number of PKD mutations, multiple genes are
involved in renal eystogenesis. However, to date, only the PKD1
locus has been identified and sequenced [16-18]. None of the
other genes have been cloned. No putative human genetic mod-
ifier has been mapped and the molecular pathogenesis of renal
cyst formation in human PKD remains undefined.
As a complementary research model, the mouse provides
several experimental systems to study the pathogenesis of poly-
cystic kidney disease. Numerous mouse cystic kidney mutations
have been described [19-25]. While each mouse mutation is
transmitted as a single recessive trait, the mutant phenotypes
resemble the full range of human PKD. Three mutations, cpk,
hpk, and the insertional mutation, Tg737Rpw, phenotypically
resemble human ARPKD [19, 20, 26]. In contrast, the renal
lesions in the pcy, jck, and jcpk mouse models correspond more
closely to that evident in human ADPKD. As in human PKD,
genetic background affects the disease phenotype in most of these
mouse PKD models [20-22, 27, 28]. Recently, modifier genes have
been mapped to Chromosome (Chr) I and Chr 10 for jck, Chr 4
and Chr 16 forpcy as well as for cpk [22, 29, 30]. Therefore, in a
pattern analogous to human disease, multiple genes appear to be
involved in renal cystogenesis in the mouse. It is tempting to
speculate that at least some of these genes operate in common
molecular pathways. However, this hypothesis has been difficult to
address since none of the previously mapped mutations are allelic,
and based on map positions, none are candidate modifier loci for
any of the other mouse PKD mutations.
Previously we have described the mouse bpk mutation that
arose spontaneously in the BALB/c strain [19]. In this model, dual
renal tubular and biliary epithelial abnormalities are present in a
pattern that closely resembles human ARPKD. We now report
the localization of the bpk mutation on mouse Chr 10, and
document that the severity of the renal cystic disease in our
intersuhspeeific intercross progeny is clearly influenced by genetic
background. Because this mutation maps close to the jcpk, a
phenotypieally-distinct PKD mutation, we performed a comple-
mentation test. Our data demonstrate that the bpk and jcpk
mutations are allelic. Interestingly, the phenotype in the bpk/jcpk
compound heterozygotes closely resembles that of bpklbpk ho-
mozygotes. Finally, we note that based on its map position, the
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bpk locus is a candidate modifying gene for jck, a third phenotyp-
ically-distinct PKD mutation.
Methods
Mice and phenotype characterization
The bpk mutation arose spontaneously in the BALB/c inbred
strain and has been transmitted as a stable recessive trait for over
40 intercrossed generations [191. The mice used in these studies
were from a sub-colony that has been maintained at the University
of Alabama at Birmingham for four generations.
The jcpk mutation was induced by chiorambucil mutagenesis of
(101 x C3H/HeJ)F2 mice. Males were then mated to normal
females of the Tester strain. The Fl pups were intercrossed twice
and the jcpk phenotype was first observed in the resulting progeny.
The jcpk colony has been maintained by backcrossing test-proven
+/jcpk males to normal C57BL/6J females [241. The jcpk mice
used in these studies were from this colony maintained at the
Wadsworth Center (Albany, NY, USA).
For both mutations, individuals heterozygous for the mutant
allele were identified in each generation by test-crossing pheno-
typically normal individuals to known heterozygotes.
CAST/Ei mice, an inbred strain derived from the wild mouse
species Mus musculus castaneus (CAST), were obtained from The
Jackson Laboratory (Bar Harbor, ME, USA).
To map the bpk mutation genetically, BALB/c-+/bpk heterozy-
gotes were bred to CAST/Ei mice, and Fl! progeny heterozygous
for the hpk mutation, identified by test crossing, were intercrossed
to generate F2 mice. Initially, offspring affected with cystic kidney
disease died between 14 and 21 days after birth, so subsequent F2
litters were sacrificed 14 days after birth. The F2 pups were
dissected and examined visually for the presence of enlarged cystic
kidneys, gallbladder distension and abnormal biliary tracts.
To assess the severity of the renal cystic disease, we initially
analyzed kidney weight alone, kidney weight as a function of body
wt, and kidney length alone as well as the kidney length as a
fraction of crown-rump length (K/C-R ratio). While in each data
set, the variance in the F2 bpk/bpk pup parameters was greater
than for the BALB bpklbpk pups, the K/C-R ratio was the most
convenient and reproducible index of disease severity. For all
progeny, gross renal and biliary abnormalities were confirmed by
histopathologic analysis. Whole kidneys and livers were removed
and fixed in 70% alcoholic formalin (10% formalin in 70%
ethanol). Paraffin sections were stained with hematoxylin and
eosin and examined microscopically.
Complementation testing was performed at the Wadsworth
Center. Three breeding pairs of test-proven BALB/c-+Ibpk and
+/jcpk heterozygotes were crossed. Progeny were sacrificed Ii to
17 days after birth and scored as above for visible and histopatho-
logical evidence of cystic kidney disease and biliary abnormalities.
PCR-hased genotyping
To type progeny for inheritance of alleles of anonymous DNA
microsatellite markers, liver genomic DNA was prepared accord-
ing to standard protocols. Microsatellite markers whose BALB/e
and CAST/Ei alleles differed in size by at least 6 base pairs (bp)
and which mapped to proximal and distal ends of each chromo-
some (chromosome end-mapping study), to 10 cM intervals spaced
along Chromosome 10 (low-resolution linkage mapping study), or
within 3 M of DlOMitI99 (high-resolution linkage mapping study),
were chosen from the on-line Whitehead/MIT database (accessi-
ble at http://www-genome.wi.mit.edu!; described by Dietrich et al
[31]). PCR primer pairs for these markers were purchased from
Research Genetics, Inc. (Huntsville, AL, USA).
Forward primers were end-labeled with y32P-adenosine
triphosphate, and PCR amplification was performed as described
by Dietrich et al [31]. Amplified fragments were analyzed on
denaturing 6% polyacrylamide gels.
Analysis of genetic data
Genotype data obtained by analyzing 42 affected F2 progeny for
microsatellite markers known to map to the ends of each auto-
some were subjected to end-mapping analysis exactly as described
by lakoubova, Dushkin and Beier [221. To construct low- and
high-resolution linkage maps, individual chromosomal haplotypes
were inferred from F2 genotypic data as described previously [321,
and markers were ordered so as to minimize the numbers of
crossover events needed to account for the inferred haplotypes.
Results
(BALBIc- + Ibpk X CAST)F1 intercross
In our (BALBIc-+/bpk X CAST)F1 intercross, Fl +/hpk hy-
brids were identified by progeny testing. While we have not
formally evaluated our Fl pups, they have exhibited no manifes-
tations of disease and both F] males and females breed in a robust
fashion.
Of the 530 F2 progeny generated to date, 124 (23.4%) have
recessive PKD. The number of F2 bpk/bpk pups is consistent with
that expected for the Mendelian inheritance of a single recessive
trait. Among the F2 progeny, the affected pups were significantly
runted shortly after birth as compared with normal litter mates.
They developed prominent abdominal distension by 9 to 15 days
of age and rapid progression to death by 21 days. In comparison,
abdominal distension is not detected in the BALBIc-bpklbpk pups
until after two weeks of age and these pups typically survive to 4
to 5 weeks of age [19]. Gross inspection of the F2 pups at necropsy
at 14 days revealed markedly enlarged kidneys with a cystic
pattern reminiscent of BALB/c-bpk/hpk mice at 24 to 28 days of
age. The K/C-R was normally distributed in both the F2 (Fig. 1)
and parental populations (data not shown). The mean K/C-R was
0.36 0.8 for the F2 pups as compared with 0.35 0.2 for the
BALB/c-bpk/bpk homozygotes (N = 12). An F test of these
variances confirmed that they are statistically different (P <
0.001). In addition, the liver parenchyma in these F2 affected pups
was pale and marked gallbladder dilation was common. Prelimi-
nary examination of 10 F2 hpk/bpk livers suggested that as with
the renal lesion, the severity of the biliary lesion is variable in the
intercross pups (data not shown). Direct visual inspection failed to
reveal evidence of other visceral, cranial or skeletal abnormalities.
Genetic mapping of bpk
To expedite the process of assigning bpk to a chromosome, we
applied the end-mapping strategy of lakouhova et al [22] to 42
affected F2 progeny of the (BALB/c-+/bpk X CAST)F1 inter-
cross. In effect, by typing only markers at the ends of each
chromosome, we generated a series of "chromosomal haplotypes"
for each mutant mouse. Among the progeny of an intercross, a
proportion of the F2 pups will inherit chromosomes that are
apparently non-recombinant, that is, the alleles of markers along
0.15 0.25 0.35 0.45 0.55
K/C-A
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identify a cohort of candidate chromosomes for more detailed
analysis using standard recombinational mapping techniques.
For two chromosomes, Chr 10 and 18, a significant paucity of
apparently non-recombinant CAST haplotypes (NRCAST) was
observed. For Chr 10, 2 NRCAST were observed versus 19.6
expected among 68 informative chromosomes, g (1 d.f.) = 21.77,
P < 0.0001, whereas for Chr 18, 6 NRCAST were observed versus
20.2 expected among 70 informative chromosomes, x2 (1 d.f.) =
11.46, P = 0.0007. These data are consistent the hypothesis that
either of these chromosomes harbors the bpk gene. Because the
paucity of NRCAST was particularly dramatic in the case of Chr 10,
we first typed the 42 affected F2 progeny for a series of anony-
mous DNA microsatellite markers known to be spaced at —-10 cM
intervals along this chromosome. As shown in Figure 2, these data
position bpk within a 3.6 CM interval centered on DIOMitl99.
Additional F2 pups (total: 124 pups/248 meioses) were then typed
with the immediately flanking markers and recombinational map-
ping was used to further refine the localization. These data,
summarized in Figure 3, establish that the bpk locus lies within a
1.6 CM interval flanked by DlOMitll5 and DlOMitI73!Mit199/
Mit200.
These results, coupled with the fact that bpk is transmitted as a
single recessive trait in both the BALB/c strain and our (BALB/
c-+Ibpk X CAST)F1 intereross, confirm that the bpk disease-
susceptibility locus maps to Chr 10. Therefore, no further map-
ping analyses were performed for Chr 18.
Allele testing with +!jcpk hetero2ygotes
Fig. 1. The distribution of the kidney lesion severity in the F2 bpklbpk pups.
Necropsy at 14 days revealed massively enlarged kidneys in each F2
bpk/bpk pup. In order to quantitatively assess the severity of the kidney
lesion, the ratio of kidney length to crown-rump length (KJC-R) was
measured in each pup. This ratio corrected the renal size for the degree of
linear growth retardation and was highly reproducible. Therefore, among
the possible parameters to assess the severity of renal disease, the K/C-R
was the most reliable. While the mean KJC-R in the F2 pups (0.36 0.08;
data presented as the mean SD) was quite similar to that in BALB/c-
hpk/bpk pups (0.35 0.02; data not shown), the variance in the F2 K/C-R
was fourfold larger. An F test of these variances confirms that they are
statistically different (P < 0.001). These data are consistent with the
presence of modifying loci in the CAST genetic background which
accelerate the progression of the renal cystic disease severity in the F2
intercross pups. The relatively large variance in the F2 KIC-R suggests that
relatively few modifying loci are involved [36].
these chromosomes will correspond to a single parental strain, in
this case either BALB/c or CAST. In the analysis of a recessive
mutation like bpk, only non-recombinant chromosomes (NR) that
are inherited from the disease-bearing strain (BALB/e) can carry
the mutation. For non-linked chromosomes, there is a random
distribution of NR chromosomes for each parental strain. In
contrast, for a linked chromosome, that is, the one carrying the
bpk mutation, there will be a paucity of CAST NR chromosomes.
Therefore, this strategy provides an efficient method to exclude
chromosomes that are unlikely to carry the mutation and to
As shown in Figure 3, the bpk locus co-localized with the
previously assigned map position for the jcpk mutation. To test
whether these mutations were allelic, test-proven +Ibpk and
+/jcpk heterozygotes were crossed. Of the 19 Fl pups, six (31%)
developed abdominal distension by 7 to 10 days of age. In all six
affected pups, necropsy at 11 to 17 days revealed markedly
enlarged kidneys that were studded with small opalescent cysts.
The liver parenchyma in these Fl affected pups was pale and
marked gallbladder dilatation was evident. Direct visual inspec-
tion failed to reveal the presence of other visceral, cranial or
skeletal abnormalities. A detailed histopathologic survey will be
required to assess the severity of the kidney and biliary lesions and
to evaluate other organs at a microscopic level for associated
abnormalities. These analyses are in progress.
Given that both bpk and jcpk are recessive mutations, the
expression of a mutant phenotype in approximately one quarter of
the Fl offspring indicates that these mutations are allelic. How-
ever, we did explore the alternative possibility that on the BALB/c
background, the jcpk gene acts in a dominant fashion with variable
penetrance. Specifically, we crossed test-proven +/jcpk heterozy-
gotes and wild-type BALB/c mice. No affected Fl pups were
detected (N = 12). Moreover, we have no evidence of dominant
early onset PKD caused by either of the bpk or jcpk genes on any
other genetic background, including CAST. Therefore, given the
co-localization of these genes on Chr 10 and the presence of
affected pups in a standard allelism test, we believe that the
simplest hypothesis is that these mutations are allelic.
Comparative histopatholoy
In bpklbplc homozygotes the renal cysts are radially arrayed
from the cortex to the medulla, in a pattern typical of cystic
collecting ducts (Fig. 4A). The predominance of collecting duct
23/84 = 27.4±4.9
6
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Fig. 2. Genetic localization of bpk on Chromosome 10. (A) Haplotype distribution among 84 test chromosomes from the (BALB/c-bpk/+ X CAST)F1
intercross. For each locus, solid boxes represent the inheritance of BALB/c-derived alleles from the mutant chromosome, and open boxes represent the
inheritance of CAST-derived alleles. The number of chromosomes for each haplotype is shown below the columns. (B) Genetic map of Chr 10
constructcd from the haplotype distribution in (A). The map distances, in c, were calculated from the recombination frequency observed for each
interval and are expressed with standard errors.
involvement has previously been confirmed by lectin-binding
studies [19]. In our analyses, we noted occasional cystic dilatation
of Bowman's spaces, involving 6% of the glomeruli. In contrast, in
jcpkljcpk homozygotes, the kidney lesion is remarkable for dila-
tation of Bowman's space in 95% of the glomeruli, as well as cysts
in both proximal and distal tubular elements (Fig. 4E). In the
bpk/jcpk compound heterozygote, the cysts are arrayed in a radial
fashion, very similar to the cystic pattern seen in bpklbpk kidneys
(Fig. 4C). Dilation of Bowman's space was evident in 17% of the
glomeruli and normal proximal tubular elements were seen. Thus,
in the compound heterozygote, the renal cystic phenotype appears
to more closely resemble that manifest in bpk!bpk homozygotes.
Previous analysis of the portal tracts from both the bpk/bpk and
jcpk/jcpk homozygotes revealed evidence for biliary dysgenesis
[19, 24]. Similarly, in the six bpk/jcpk compound heterozygotes,
the portal tracts are expanded with multiple irregularly shaped
and variably dilated bile ducts. These tortuous ducts are generally
lined with a hyperplastic epithelium. The comparative biliaty
histopathology of these mutants is shown in Figure 5.
Discussion
Using the chromosomal exclusion method recently described by
lakoubova et al, we have rapidly and efficiently mapped the mouse
bpk mutation to a well-defined interval on Chr 10. In the course of
these mapping studies, we noted that the renal cystic phenotype
was generally more severe and more variable in the affected F2
intercross pups than in affected pups from the BALB/c parental
strain. Preliminary analyses suggest that the severity of the biliary
lesion in our affected F2 pups is also variable. These data
implicate the presence of modifying gene(s) in the CAST genetic
background that accelerate the progression of the renal cystic
disease in the F2 intercross pups. In addition, the end-analysis
genetic mapping of bpklbpk F2 progeny demonstrated a signifi-
cant paucity of Chr 18 with apparently non-recombinant CAST/Ei
haplotypes (NRCAST). A subsequent review of the disease severity
in these initial 42 pups revealed that 12 of the 42 had mild kidney
disease as assessed by a K!C-R ratio of < 0.3. Interestingly, the
majority of the informative chromosomes from this mildly affected
cohort were (NR[ALB) while the informative chromosomes from
the other 30 pups were evenly distributed as NRCAST and
NRBAIB. This result raises the possibility that a modifier of the
bpk phenotype maps to Chr 18, and that the BALB/e allele
attenuates disease severity. Taken together, these data are con-
sistent with previous reports that genetic background influences
the renal disease phenotype of the cpk, pcy andjck mutations [21,
22, 28]. Further phenotypic and genetic analysis of additional F2
progeny from this cross will he needed to resolve this issue and
specifically, to better characterize the role of genes on Chr 18 in
this cystic kidney disease model.
Our mapping data position the bpk locus within the same
discrete interval as the phenotypically distinct jcpk mutation. As a
somewhat unexpected finding, we have determined that despite
A
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their distinctly different PKD phenotypes, the bpk and jcpk
mutations appear to disrupt the same gene. However, given the
origin of each mutation, this conclusion requires some qualifica-
tion. The bpk mutation arose spontaneously in an inbred labora-
tory strain, and thus it likely represents a point mutation or a
sequence alteration involving few base pairs. In contrast, the jcpk
mutation was induced by the chemical mutagen, chlorambucil
[24]. Since all known chiorambucil mutations involve deletions or
chromosomal rearrangements, it is vety likely that jcpk involves a
significantly large genomic alteration [331. At this point, we cannot
determine whether the jcpk phenotype results from disruptions in
the same single locus as bpk or whether it involves two closely
linked genes, one of which is bpk. The latter possibility has
important precedence in PKD research because such a contiguous
gene syndrome provided the major breakthrough in the positional
cloning effort to identify the PKD1 locus [3I These two possi-
bilities will only be distinguished by identifying the candidate
gene(s) and establishing the specific mutations by sequence
analysis. Currently, efforts to isolate the disease-susceptibility
gene(s) at the bpk/jcpk locus using positional cloning strategies are
underway in our laboratories.
The Chr 10 map position of the bpk/jcpk locus also coincides
with the map position of the principal modifying gene for the jck
mutation, a third phenotypically distinct PKD model [22] (D.
Beier, personal communication). Therefore, based on these ge-
netic mapping data, the gene identified by the bpk and jcpk
mutations is also a candidate PKD modifying gene. Our data
combined with the jck data suggest that there are at least four
alleles at this putative modifying locus. The first is an allele carried
by C57BL/6J mice that appears to act as a wild-type allele and is
not associated with any defect. The second is a mild loss-of-
function allele, exemplified by the DBAI2 form of the gene.
Homozygotes for this allele do not manifest any kidney defect, but
when this allele is expressed together with mutations at the
unlinked jck locus, the cystic kidney lesion is exacerbated [22]. The
third is the bpk allele, a stronger loss-of-function allele, which in
the homozygous state causes a recessive polycystic kidney pheno-
type. The fourth is jcpk, which given its origin may be a null allele.
In homozygotes, jcpk causes particularly severe cystic kidney
disease, whereas aged heterozygotes develop a late-onset gb-
merulocystic disease phenotype that is not fully penetrant. Using
specific breeding strategies, the potential interaction of the bpkl
jcpk locus with jck is currently being investigated.
These findings have several important implications for PKD
research. First, the bpk model provides the reagents to identify
both a PKD-susceptibility gene as well as additional loci that
modify the phenotypic expression of this disease gene. Given the
histopathobogic findings in bpk/bpk homozygotes from both the
BALB/c parental strain and our intercross, it is likely that these
genes operate in a molecular pathway that is important in both
renal cystogenesis as well as in the terminal differentiation of renal
tubular and biliary epithelia. The isolation of this PKD-suscepti-
bility gene and its genetic modifiers, and ultimately examination of
their interactions, should help elucidate the molecular mecha-
nisms involved in disease pathogenesis as well as in normal renal
and biliary development.
Finally, our findings have potential ramifications for the con-
ceptual understanding of PKD. In the current nosology, human
PKD is generally classified as either ADPKD or ARPKD, based in
part on genetic transmission and in part, on histopathologic
features. Implicit in this formulation is the hypothesis that the
molecular pathogenesis of human ADPKD and ARPKD involve
distinct sets of genes. Indeed, most mouse PKD mutations are
characterized and discussed as pathologic models for either
human ADPKD or ARPKD.
ADPKD is generally considered to he a systemic disorder with
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Fig. 3. Refined genetic localization of the bpk
and jcpk mutations on Chromosome 10. (A) The
refined genetic maps for the bpk mutation and
(B) the jcpk mutation (E. Bryda, unpublished
data). For bpk, the map distances, in CM, were
calculated from the recombination frequency
observed for each interval and are expressed
with standard errors.
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Fig. 4. Comparative renal histopathology in bpk/bpk pups, F] bpk/jcpk pups, and jcpk/jcpk pups. A. The renal histopathology of a 28-day old,
BALB/c-hpk/bpk pup. The cystic dilatations are arrayed perpendicular to the renal capsule in a pattern most consistent with collecting duct involvement.
Occasional cystic dilatations of Bowman's space are evident (H&E >< 100). B. The area of detail from panel A. While the majority of cystic tubules in
the bpk/bpk kidney are lined by a flattened epithelium (large arrow), occasionally the cyst-lining epithelia exhibit a brush border (small arrow), suggestive
of proximal tubular origin. In 6% (6/100) of the glomeruli, Bowman's space is dilated (open arrow; H&E x600). C. The cystic kidneys from a 14-day
old, Fl bpk/jcpk compound heterozygote. The histopathology closely resembles that of bpk/bpk homozygotes. The predominant lesion involves radially
arrayed cystic tubules and occasional cystic dilations of Bowman's space are evident (H&E X 100). D. The area of detail from panel C. While the majority
of glomeruli are normal, Bowman's space is dilated (open arrow) in 17% (17/100) (H&E x600). E. The renal histopathology in a seven days old,
C57BL/bJ- jcpk/jcpk pup. In contrast to the cystic lesions evident in both bpk/bpk homozygotes and Fl jcpk/bpk heterozygotes, in the jcpk/jcpk kidney
extensive cystic dilation involves Bowman's space, as well as virtually all tubular elements from the renal pelvis (large arrow) to the cortex. The terminal
phase of normal nephrogenesis is evident in the subeapsular region (small arrows) (H&E >< 100). F. The area of detail from panel F. At higher
magnification, the dilated tubules appear to he of heterogeneous origin. Some tubules are lined by cuboidal epithelia with an associated brush border,
suggesting proximal tubular origin (small arrow). The radially arrayed tubules are lined with a flattened epithelia consistent with a distal tubular origin.
The most striking feature of these cystic kidneys is the dilatation of Bowman's space (open arrow) in 95% (95/100) of the glomeruli (H&E X600).
abnormalities occurring in several epithelial organs (kidney, liver,
pancreas, lung) as well as the heart and the vasculature. In the
kidney, cysts can arise anywhere along the nephron length, from
the glomerulus to the collecting duct [2]. In comparison, ARPKD
is a malformation complex that involves only the kidney and liver.
The predominant renal cystic lesion is confined to the collecting
ducts [31. However, careful clinical review reveals that there can
be phenotypic overlap between ADPKD and ARPKD. For exam-
ple, in a subset of ADPKD families, affected children can present
in the neonatal period with massively enlarged kidneys that are
I •' •s . . •. — a • # •. -.
_.:j-e' • - •' : .! • : .r.e.ót4'. ;
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Fig. 5. Comparative biliaiy histopathology. A. The normal portal triad histology from a 14-day-old BALB/c pup. The portal vein is indicated by the large
arrows and the associated bile ductules by the smaller arrows (H&E ><250). The mild portal vein dilation was interpreted as normal and presumed to
he age-related since the same findings were evident in age-matched DBA!2J pups (data not shown). B. The biliary histopathology of a 28-day-old
BALB/c-bpk/bpk pup. The bile ductule is curvilinear and lined by hyperplastic epithelia (H&E ><250). C. The portal triad from a 14-day-old Fl bpk/jcpk
compound heterozygote. As in both the BALB/c-bpk/bpk and the C57BL/6J-jcpk/jcpk homozygotes, the bile ductules are branched and lined by
hyperplastic epithelia. In addition, the portal triad is expanded in part by hematopoetic cells and in part by immature stromal cells (H&E x250). D.
The hiliary histopathology of a seven days old, C57BL/6J-jcpk/jcpk pup. The branched bile ductules are lined by hyperplastie cpithelia and the portal
triad is expanded by both hematopoetic cells and immature stromal cells (H&E )<250).
reminiscent of ARPKD. Often these infants have a more virulent
clinical course that is similar to ARPKD infants and characterized
by the development of hypertension and renal insufficiency. In
addition, case reports suggest that while biliary dysgensis leading
to congenital hepatic fibrosis is an invariant finding in ARPKD, it
also can occur in ADPKD [31. And finally, in a minority of
children with PKD, the renal and hiliary histopathology dei
classification according to standard guidelines (L. Guay-Wood-
ford, unpublished data). Therefore, while in human PKD the
disease-susceptibility loci for ADPKD and ARPKD are distinct
and separate, molecular pathways may be shared.
In this context, our finding that a single PKD gene can be
involved in different PKD phenotypes is particularly intriguing. To
our knowledge, these data have no prior precedent in PKD
although there is ample precedence for this phenomenon with
other mouse loci. Perhaps the most compelling example involves
mutations in the mouse agouti (a) locus which result in pheno-
types ranging from dominant gain-of-function to a series of
loss-of-function recessive alleles that can be ranked in order of
severity like the model we have suggested for bpk!bpk, bpk/jcpk,
and jcpk/jcpk [351• Therefore, we propose that different mouse
PKD models may share aspects of molecular pathogenesis and by
extension, genetic investigations in mouse models such as bpk
have important implications for dissecting the molecular patho-
genesis of human PKD.
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